243 related articles for article (PubMed ID: 16500246)
1. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
Sturgeon C; Shen WT; Clark OH; Duh QY; Kebebew E
J Am Coll Surg; 2006 Mar; 202(3):423-30. PubMed ID: 16500246
[TBL] [Abstract][Full Text] [Related]
2. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas.
Shen WT; Sturgeon C; Clark OH; Duh QY; Kebebew E
Surgery; 2004 Dec; 136(6):1129-37. PubMed ID: 15657566
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of adrenal cortical carcinoma in the United States.
Paton BL; Novitsky YW; Zerey M; Harrell AG; Norton HJ; Asbun H; Kercher KW; Heniford BT
Surgery; 2006 Dec; 140(6):914-20; discussion 919-20. PubMed ID: 17188138
[TBL] [Abstract][Full Text] [Related]
4. Adrenal incidentalomas: risk of adrenocortical carcinoma and clinical outcomes.
O'Neill CJ; Spence A; Logan B; Suliburk JW; Soon PS; Learoyd DL; Sidhu SB; Sywak MS
J Surg Oncol; 2010 Oct; 102(5):450-3. PubMed ID: 20734420
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
Menon V; Krishnamurthy SV
Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note.
Gonzalez RJ; Shapiro S; Sarlis N; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
Surgery; 2005 Dec; 138(6):1078-85; discussion 1085-6. PubMed ID: 16360394
[TBL] [Abstract][Full Text] [Related]
7. Outcome of adrenocortical tumors in children.
Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
[TBL] [Abstract][Full Text] [Related]
8. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
[TBL] [Abstract][Full Text] [Related]
9. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
[TBL] [Abstract][Full Text] [Related]
10. [A clinical analysis of 103 cases of adrenal incidentaloma].
Tao H; Lu ZL; Li HZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):172-5. PubMed ID: 12905714
[TBL] [Abstract][Full Text] [Related]
11. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review.
Advani A; Vaikkakara S; Gill MS; Arun CS; Pearce SH; Ball SG; James RA; Lennard TW; Bliss RD; Quinton R; Johnson SJ
J Clin Pathol; 2008 Aug; 61(8):939-44. PubMed ID: 18515402
[TBL] [Abstract][Full Text] [Related]
12. Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality.
Nguyen MM; Gill IS
J Urol; 2009 Mar; 181(3):1020-7; discussion 1027. PubMed ID: 19150563
[TBL] [Abstract][Full Text] [Related]
13. Risk of concomitant malignancy in hyperfunctioning adrenal incidentalomas.
Allan BJ; Thorson CM; Van Haren RM; Parikh PP; Lew JI
J Surg Res; 2013 Sep; 184(1):241-6. PubMed ID: 23562276
[TBL] [Abstract][Full Text] [Related]
14. Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database.
Canter DJ; Mallin K; Uzzo RG; Egleston BL; Simhan J; Walton J; Smaldone MC; Master VA; Bratslavsky G; Kutikov A
Can J Urol; 2013 Oct; 20(5):6915-21. PubMed ID: 24128829
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.
Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C
Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179
[TBL] [Abstract][Full Text] [Related]
17. Myxoid adrenal cortical neoplasms.
Raparia K; Ayala AG; Sienko A; Zhai QJ; Ro JY
Ann Diagn Pathol; 2008 Oct; 12(5):344-8. PubMed ID: 18774497
[TBL] [Abstract][Full Text] [Related]
18. Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors?
Dehner LP; Hill DA
Pediatr Dev Pathol; 2009; 12(4):284-91. PubMed ID: 19326954
[TBL] [Abstract][Full Text] [Related]
19. Limitations of size as a criterion in the evaluation of adrenal tumors.
Barnett CC; Varma DG; El-Naggar AK; Dackiw AP; Porter GA; Pearson AS; Kudelka AP; Gagel RF; Evans DB; Lee JE
Surgery; 2000 Dec; 128(6):973-82;discussion 982-3. PubMed ID: 11114632
[TBL] [Abstract][Full Text] [Related]
20. Malignant and unclear histological findings in incidentalomas.
Duenschede F; Bittinger F; Heintz A; Musholt T; Korenkov M; Kann P; Ewald P; Gockel I; Junginger T
Eur Surg Res; 2008; 40(2):235-8. PubMed ID: 18032908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
